Stock listing

Whitehawk Therapeutics, Inc.

Selected listing: 3350 · DUS · EUR · DE

Whitehawk Therapeutics, Inc. (Dusseldorf:3350), Health Technology. Latest release Oct 1, 2026: Whitehawk Therapeutics Presents Real-World Analyses Supporting…

3350:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:3350
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Dusseldorf
Currency: EUR

Latest news from Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026

September 30, 2026

Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026

October 1, 2026

Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026

September 12, 2026

Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

September 10, 2026

Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

July 6, 2026

All Whitehawk Therapeutics, Inc. news →

Events

Replays

Whitehawk Therapeutics, Inc. (WHWK) Q4 2024 Earnings Call
Wed, Mar 19, 2025 · 08:30 AM ET
Watch
Aadi Bioscience, Inc. (AADI) Q2 2024 Earnings Call
Wed, Aug 07, 2024 · 08:30 AM ET
Watch
Aadi Bioscience, Inc. (AADI) Q1 2024 Earnings Call
Wed, May 08, 2024 · 08:30 AM ET
Watch

Research Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc. company profile

View the public company page for Whitehawk Therapeutics, Inc. on 6ix.

Whitehawk Therapeutics, Inc. news

Read company news and market updates connected to Whitehawk Therapeutics, Inc..

Whitehawk Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Whitehawk Therapeutics, Inc..